ESR1 and endometrial cancer: FOXA1 has previously been shown to regulate distinct transcriptional programs in cells of different linages [26], and the clinical experience with increased endometrial cancer risk amongst women with ERα positive breast cancers treated with Tamoxifen also supports organ specific differences in the hormone regulation.